Trinity Biotech ADR buy StockNews.com
Start price
30.04.23
/
50%
€0.96
Target price
30.04.24
-
Performance (%)
-56.86%
End price
01.05.24
-
Summary
This prediction is currently being closed. The BUY prediction by StockNews_com for Trinity Biotech ADR is performing very badly with a performance of -56.86%. StockNews_com has a follow-up prediction for Trinity Biotech ADR where he still thinks Trinity Biotech ADR is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Trinity Biotech ADR | - | - | - |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten